The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of patients with metastatic renal cell carcinoma who discontinued nivolumab +/- ipilimumab therapy electively or due to toxicity.
 
Jessica Heejin Yoo
No Relationships to Disclose
 
Duncan Hussey
No Relationships to Disclose
 
Evan Gross
No Relationships to Disclose
 
Sarah P. Psutka
Honoraria - AstraZeneca
Consulting or Advisory Role - Janssen; Merck
Travel, Accommodations, Expenses - medtronic
 
Scott S. Tykodi
Honoraria - FirstWord; Natera; Targeted Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; Merck
Research Funding - AVEO (Inst); Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Exelixis (Inst); Genentech (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending (Inst)
 
John A. Thompson
Consulting or Advisory Role - Academy for Continued Healthcare Learning; Alpine Immune Sciences; AVEO; BJ Bioscience; Bristol-Myers Squibb; Calithera Biosciences; Clinical Care Options/NCCN; Meeting Sites Pro; Neoleukin Therapeutics; Regeneron
Research Funding - Agensys (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PMV Pharma (Inst); Roche (Inst); Trillium Therapeutics (Inst); Xencor (Inst); Xencor (Inst)
 
Evan Thomas Hall
Research Funding - ImCheck therapeutics (Inst); Nektar (Inst); Neoleukin Therapeutics (Inst); Treatment Technologies and Insights (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Cancer Support Community